Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
达雷妥尤单抗四联疗法用于适合移植且新诊断为多发性骨髓瘤、具有高细胞遗传学风险的患者
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01030-w
Callander, Natalie S; Silbermann, Rebecca; Kaufman, Jonathan L; Godby, Kelly N; Laubach, Jacob; Schmidt, Timothy M; Sborov, Douglas W; Medvedova, Eva; Reeves, Brandi; Dhakal, Binod; Rodriguez, Cesar; Chhabra, Saurabh; Chari, Ajai; Bal, Susan; Anderson, Larry D Jr; Dholaria, Bhagirathbhai R; Nathwani, Nitya; Hari, Parameswaran; Shah, Nina; Bumma, Naresh; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Giri, Smith; Costa, Luciano J; Usmani, Saad Z; Richardson, Paul G; Voorhees, Peter M
